| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.001 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.001 |